Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2802 (LINC02802)
- Target
- LINC02802
- Molecular classification
- Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01
Overview
Long intergenic non-protein coding RNA 2802 (LINC02802) is a human long non-coding RNA transcript categorized as a long intergenic non-protein coding RNA (lincRNA), meaning it is a non-coding transcript greater than 200 nucleotides in length that does not overlap a protein-coding gene.[1][3][5] LincRNAs are a major subclass of long non-coding RNAs, typically found in the nucleus, where they function primarily in the regulation of gene expression, chromatin architecture, and genomic organization.[5][7] LINC02802, cataloged under Ensembl ID ENSG00000232527 and NCBI Gene ID 100996732, has not been reported as functionally characterized or disease-associated in the present scientific literature or curated gene resources.[1][3][5] As such, it is not considered a therapeutic target, no drugs are known to interact with it, and its function remains to be elucidated.
- Other names
- LINC02802Long intergenic non-protein coding RNA 2802ENSG00000232527Gene ID 100996732
02
Mechanism of action
Not applicable; there are no drugs targeting this lincRNA
03
Biological functions
Gene regulation: lincRNAs can regulate the expression of neighboring or distant genes through chromatin modification, transcriptional regulation, and RNA stabilityChromatin remodeling and genome architecture: alter chromatin states, scaffold proteins, and interact with genomic DNAFine-tuning of gene expression with possible tissue-specific functionsPotential roles in cell development and differentiation (as with other lincRNAs), but specific functions for LINC02802 are uncharacterized in the current literature
04
Disease associations
Other: There is no evidence for a specific or direct association of LINC02802 with major disease categories such as cancer, inflammation, neurodegenerative, cardiovascular, or infectious disease as of current gene and functional annotationLincRNAs in general are increasingly associated with disease mechanisms, but no disease roles are reported for LINC02802 specifically
05
Safety considerations
None known or reported, as LINC02802 is not a therapeutic or drug target
06
Interacting drugs
None reported
07
Biomarkers
None established or reported
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2802 (LINC02802).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2802 (LINC02802).